DC1s shield Tpex cells to bolster PD-1 blockade - ScienceDirect

Blockade of PD-1/PD-L1 increases effector T cells and aggravates

Frontiers PD-1 Immune Checkpoint Blockade and PSGL-1 Inhibition

Frontiers PD-1 Immune Checkpoint Blockade and PSGL-1 Inhibition

Cell-penetrating poly(disulfide)-based nanoquenchers (qCPDs) for

Frontiers The PD-1/PD-L1 Pathway Affects the Expansion and

Side-Bi-Side Cells - PermeGear

Shield1 ligand

PD-1 blockade therapy promotes infiltration of tumor-attacking

Lymph nodes: at the intersection of cancer treatment and

RHGF-1/PDZ-RhoGEF and retrograde DLK-1 signaling drive neuronal

Blockade of PD-1/PD-L1 increases effector T cells and aggravates

Development of Antibody-Based PROTACs for the Degradation of the

Nanoparticle Conjugation Stabilizes and Multimerizes β-Hairpin

Blockade of PD-1/PD-L1 increases effector T cells and aggravates